BioSpace News Archive

Quince Therapeutics, Inc. (Nasdaq: QNCX), announced that the company will present at a number of scientific meetings taking place in September 2022, including the 14th International Conference on Osteogenesis Imperfecta (OI 2022), The American Society for Bone and Mineral Research Annual Meeting (ASBMR 2022), and the Military Health System Research Symposium (MHSRS 2022).

Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Morgan Stanley 20th Annual Global Healthcare Conference on Wednesday, September 14, 2022.

According to Vision Research Reports, the rare disease genetic testing market was valued at USD 785.95 million in 2021 and it is predicted to surpass around USD 2.77 billion by 2030 with a CAGR of 15.02% from 2022 to 2030.

The global Stem Cells market size is expected to be worth around US$ 28.4 billion by 2030, according to a new report by Vision Research Reports.

According to Vision Research Reports, the rare diseases treatment market was surpassed at USD 119.71 billion in 2021 and is expected to hit around USD 335.99 billion by 2030, growing at a CAGR of 12.15% from 2022 to 2030

Wilmington, Delaware, United States, Transparency Market Research Inc. – Next generation sequencing for tumor and germline DNA is required for oncology screening for therapeutic application

Wilmington, Delaware, United States, Transparency Market Research Inc. – Vitiligo is a hypopigmentation skin disorder that causes the loss of skin color due to low concentration of melanin in the skin cells.

Wilmington, Delaware, United States, Transparency Market Research Inc. – The global injectable drugs market is relied upon to enlist a strong double-digit CAGR within the forecast period from 2019 to 2027.

The kidney transplant market has been projected to grow at a noteworthy speed in the foreseeable years.

Alpha Tau Medical Ltd. (Nasdaq: DRTS and DRTSW), (“Alpha Tau” or the “Company”), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, reported second quarter 2022 financial results and provided a corporate update.